Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Kevin R. Haas"'
Autor:
Valentina S. Vysotskaia, Gregory J. Hogan, Genevieve M. Gould, Xin Wang, Alex D. Robertson, Kevin R. Haas, Mark R. Theilmann, Lindsay Spurka, Peter V. Grauman, Henry H. Lai, Diana Jeon, Genevieve Haliburton, Matt Leggett, Clement S. Chu, Kevin Iori, Jared R. Maguire, Kaylene Ready, Eric A. Evans, Hyunseok P. Kang, Imran S. Haque
Publikováno v:
PeerJ, Vol 5, p e3046 (2017)
The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer
Externí odkaz:
https://doaj.org/article/2583b6401d394609b0e50fd51a04e636
Autor:
Mark R. Theilmann, Rachel A. S. Kjolby, Diana Jeon, Kevin R. Haas, Dale Muzzey, Clement Chu, Helen Y. Wan, James D. Goldberg, Noah C. Welker, Albert Lee
Publikováno v:
Genetics in Medicine
Purpose The percentage of a maternal cell-free DNA (cfDNA) sample that is fetal-derived (the fetal fraction; FF) is a key driver of the sensitivity and specificity of noninvasive prenatal screening (NIPS). On certain NIPS platforms, >20% of women wit
Autor:
Kaylene Ready, Kevin R. Haas, Piotr Kaleta, Laura M. Melroy, Shera Kash, Kelly A. Pierce, Dale Muzzey, Hyunseok Kang, Jillian I. Johnson
Publikováno v:
The Journal of Molecular Diagnostics. 21:296-306
Clinical genomic tests increasingly use a next-generation sequencing (NGS) platform due in part to the high fidelity of variant calls, yet rare errors are still possible. In germline DNA screening, failure to correct such errors could have serious co
Autor:
Dale Muzzey, Kevin R. Haas, James D. Goldberg, Rachel A. S. Kjolby, Noah C. Welker, Mark R. Theilmann, Clement Chu, Albert Lee, Helen Y. Wan, Diana Jeon
PurposeThe percentage of a maternal cell-free DNA (cfDNA) sample that is fetal-derived (the fetal fraction; FF) is a key driver of the sensitivity and specificity of noninvasive prenatal screening (NIPS). On certain NIPS platforms, >20% of women with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08cfff66a3f9afc93b47fdf556fd645e
https://doi.org/10.1101/2020.07.12.20034926
https://doi.org/10.1101/2020.07.12.20034926
Autor:
Kevin R. Haas, Rachel A. S. Kjolby, Albert Lee, Mark R. Theilmann, Clement Chu, James D. Goldberg, Helen Y. Wan, Dale Muzzey, Noah C. Welker, Diana Jeon
Publikováno v:
American Journal of Obstetrics and Gynecology. 224:S417-S418
Autor:
Dale, Muzzey, Shera, Kash, Jillian I, Johnson, Laura M, Melroy, Piotr, Kaleta, Kelly A, Pierce, Kaylene, Ready, Hyunseok P, Kang, Kevin R, Haas
Publikováno v:
The Journal of molecular diagnostics : JMD. 21(2)
Clinical genomic tests increasingly use a next-generation sequencing (NGS) platform due in part to the high fidelity of variant calls, yet rare errors are still possible. In germline DNA screening, failure to correct such errors could have serious co
Autor:
Kaylene Ready, Kevin R. Haas, H. Peter Kang, Kelly A. Pierce, Piotr Kaleta, Laura M. Melroy, Dale Muzzey, Shera Kash, Jillian I. Johnson
Clinical genomic tests increasingly utilize a next generation sequencing (NGS) platform due in part to the high fidelity of variant calls, yet rare errors are still possible. In hereditary cancer screening, failure to correct such errors could have s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7429cb0051ce2cf0c994cb67df308a1e
https://doi.org/10.1101/305011
https://doi.org/10.1101/305011
Autor:
Hyunseok P. Kang, Imran S. Haque, Sun Hae Hong, Clement Chu, Eric A. Evans, Diana Jeon, Lai Henry H, Rebecca Mar-Heyming, Kyle A. Beauchamp, Valentina Vysotskaia, Peter V. Grauman, Gregory J. Hogan, Dale Muzzey, Shera Kash, Stefanie Seisenberger, Laura M. Melroy, Jared Maguire, Kevin Iori, Kevin R. Haas, Mark R. Theilmann
Publikováno v:
Clinical chemistry. 64(7)
BACKGROUND By identifying pathogenic variants across hundreds of genes, expanded carrier screening (ECS) enables prospective parents to assess the risk of transmitting an autosomal recessive or X-linked condition. Detection of at-risk couples depends
Autor:
Saurav Guha, Lai Henry H, Sun Hae Hong, Gregory J. Hogan, Laura M. Melroy, Shera Kash, Jared Maguire, Hyunseok P. Kang, Imran S. Haque, Diana Jeon, Valentina Vysotskaia, Kyle A. Beauchamp, Peter V. Grauman, Dale Muzzey, Kevin Iori, Rebecca Mar-Heyming, Kevin R. Haas, Mark R. Theilmann, Eric A. Evans, David Jennions, Clement Chu, Kenny K. Wong, Stefanie Seisenberger
PurposeBy identifying pathogenic variants across hundreds of genes, expanded carrier screening (ECS) enables prospective parents to assess risk of transmitting an autosomal recessive or X-linked condition. Detection of at-risk couples depends on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cdaf464721f4b7bf9b5d1b9378066e3
Autor:
Alexander De Jong Robertson, Xin Wang, Diana Jeon, Valentina Vysotskaia, Imran S. Haque, Genevieve Haliburton, Matt Leggett, Lai Henry H, Clement Chu, Gregory J. Hogan, Kevin Iori, Kevin R. Haas, Peter V. Grauman, Genevieve M. Gould, Hyunseok Kang, Mark R. Theilmann, Jared Maguire, Lindsay Spurka, Eric A. Evans, Kaylene Ready
Publikováno v:
PeerJ, Vol 5, p e3046 (2017)
PeerJ
PeerJ
The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06304e18113fbf456d970d3d84a069c8
https://doi.org/10.1101/088252
https://doi.org/10.1101/088252